Drugs / Calcium Alumina-Silicate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02018653 | Dec 2013 → Aug 2014 | cancer, diarrheal disease | M.D. Anderson Cancer Center | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Calcium Alumina-Silicate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02018653 ↗ |
| Known as | CASAD | “Calcium Alumina-Silicate (CASAD)” NCT02018653 ↗ |
| Route | Oral | “1 gram by mouth every 6 hours for up to 6 days.” NCT02018653 ↗ |